Japan\'s Otsuka to apply for TB drug approval in India

2017-04-26 15:10:43

Otsuka has revealed that the company intends to apply for approval of its tuberculosis  (TB) drug Delamanid in India within 90 days. By Team ABLEJapanese pharmaceutical company Otsuka has revealed that the company intends to apply for approval of its tuberculosis  (TB) drug Delamanid in India within 90 days. According to Reuters, Otsuka’s spokesperson indicated that the company has had

Read more

India’s BioEconomy can reach $200 bn by 2030: ABLE Chief Kiran Mazumdar-Shaw

2017-04-25 11:28:57

The Current $35 billion Indian BioEconomy has the potential to first reach $100 billion by 2025 and then double to $200 billion by 2030 said the ABLE chairperson while addressing a meeting of Start-upsBy Narayanan Suresh“A $200 billion BioEconomy for India is easily achievable, “ said Dr Kiran Mazumdar-Shaw, who also chairs Biocon and Karnataka’s Vision Group on Biotechnolgoy. She made these

Read more

DBT scientists’ research infers Ashwagandha as a potential ALT cancer therapeutic

2017-04-25 10:13:14

DBT and their partner scientists have found that bioactives from Ashwagandha leaf powder have anti-cancer activitiesBy Team ABLEAshwagandha (Withania somnifera) is a popular herb in Ayurveda, the traditional home medicine native to India. A number of studies in the recent past suggested that Withanolides, Withaferin-A and Withanone, have multi-modal anticancer activities.Department of Biotechnolog

Read more

Digital Health Summer Summit to co-locate at BIO International Convention on June 19-20 in San Diego

2017-04-25 10:11:21

Both conferences will be held at the San Diego Convention Center on June 19-22, 2017, with dynamic digital health content offered to attendees all four days.By Team ABLEThe Living in Digital Times and Biotechnology Innovation Organization (BIO) have announced that the Digital Health Summer Summit (DHSS) will return to the BIO International Convention co-locating the conferences for the second year

Read more

Bangkok gears up to host global bio-economy players for the 6th Biobased Chemicals and Plastics Summit

2017-04-25 10:09:13

The summit is inspired by continued capacity additions and investments in biochemical and bioplastics industry in Asia, especially with Thailand announcing the 10-year bio-economy scheme. Reliance Industries’ Dr Vidhya Rangaswamy is a key note speaker at the summit.By Team ABLEInspired by continued capacity additions and investments in biochemical and bioplastics industry in Asia, especially wit

Read more

Glybera, world’s most expensive gene therapy medicine to go off shelves in October

2017-04-24 09:57:06

The $1 million gene therapy to treat a rare  metabolic disease lipoprotein lipase deficiency will be pulled out of the European market in October 2017 by its manufacturer, UniQure due to lack of demand for the medicineBy Narayanan SureshIts curtains for Glybera, the world’s most expensive medicine, the gene therapy, that costs $ 1 million ( approximately Rs 6.7 crore).Glybera ( alipogene tu

Read more

DBT-CDTI call for proposals under the joint Indo-Spanish program for technological co-operation in Biotechnology

2017-04-24 09:50:49

The objective of the joint Indo-Spanish program is to promote and fund market-driven research and technology development as well as to encourage partnerships and business-led R&D&I collaborative projects in the field of biotechnologyBy Team ABLEWith an aim to launch ambitious joint projects of a high international standard between Indian and Spanish organizations, a joint programme for co-

Read more

Malaria vaccines market to surge past $ 591.8 million by 2024

2017-04-24 09:49:13

According to a report on the Global Malaria Vaccines Market published by Coherent Market Insights, the market is pegged to be valued at $8.5 million in 2018 and is projected to expand at a CAGR of 102.8% during the forecast period (2018-2024)By Team ABLEAccording to the report “Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine

Read more

Narayana Hrudayalaya to buy Panacea Biotec’s NewRise Healthcare for Rs180 crore

2017-04-24 09:31:51

According to Narayana Hrudayalaya’s BSE filing the hospital has acquired Gurgaon-based multi-speciality hospital NewRise Healthcare from Panacea Biotech Ltd for Rs 180 crore.By Team ABLEDevi Prasad Shetty-founded hospital chain, Narayana Hrudayalaya has entered an agreement to acquire 100% stake in NewRise Healthcare from Panacea BiotecAccording to Narayana Hrudayalaya’s BSE filing the hospita

Read more

Electrolab to distribute Simulations Plus’ drug discovery and simulation software channel in India

2017-04-24 09:30:32

Simulations Plus has signed a distributor agreement in India with Electrolab IndiaBY TEAM ABLESimulations Plus, the NASDAQ-listed provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, has signed a distributor agreement in India with Electrolab India.John DiBella, Vice President for marketing and sales of Simulations Pl

Read more